Alnylam Pharmaceuticals, Inc. (ALNY)

Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $18.26 billion as of April 19, 2024. Its market cap has decreased by -27.49% in one year.

• Market Cap: 18.26B
• Enterprise Value: 17.13B
• 1-Year Change: -27.49%
• Ranking: #550
• Category: Large-Cap
• Stock Price: $144.41

Market Cap Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $18.26B, an increase of 13,426.62%. That is a compound annual growth rate of 27.98%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	18.28B	-0.11%
Apr 17, 2024	18.30B	-0.95%
Apr 16, 2024	18.48B	-0.66%
Apr 15, 2024	18.60B	-0.54%
Apr 12, 2024	18.70B	-2.36%
Apr 11, 2024	19.16B	-0.21%
Apr 10, 2024	19.20B	-2.24%
Apr 9, 2024	19.63B	-0.09%
Apr 8, 2024	19.65B	1.62%
Apr 5, 2024	19.34B	1.37%
Apr 4, 2024	19.08B	0.43%
Apr 3, 2024	19.00B	-0.14%
Apr 2, 2024	19.02B	-1.49%
Apr 1, 2024	19.31B	2.60%
Mar 28, 2024	18.82B	-3.20%
Mar 27, 2024	19.44B	1.59%
Mar 26, 2024	19.14B	-0.07%
Mar 25, 2024	19.15B	3.80%
Mar 22, 2024	18.45B	-0.08%
Mar 21, 2024	18.47B	-0.93%
Mar 20, 2024	18.64B	-0.12%
Mar 19, 2024	18.66B	0.52%
Mar 18, 2024	18.57B	-1.25%
Mar 15, 2024	18.80B	0.50%
Mar 14, 2024	18.71B	0.07%

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
Baxter International	20.10B
STERIS	19.66B
Genmab	19.24B
Illumina	18.70B
Waters	18.57B
Koninklijke Philips	18.43B
The Cooper Companies	17.99B
Hologic	17.63B